Daewoong Pharmaceutical Co.,Ltd sell "Luphere Depot_3.75mg-Inj."
Basic Information
453
17
4
4.6(60)
Category
Subcategory & Sub-subcategory
Trade Type
Sell
Product Name
Luphere Depot_3.75mg-Inj.
Details
Manufacturer(s)
Specifications
- Dosage Form: Sustained-release depot suspension (leuprorelin acetate 3.75 mg) for intramuscular injection, offered in spray-dried or emulsion formulation.
- Indication: Indicated for prostate cancer, endometriosis, pre-menopausal breast cancer, uterine fibroids, and central precocious puberty.
- Storage Conditions: Store refrigerated at 2-8°C, protected from light, consistent with typical leuprorelin depot handling requirements.
Other Information
Additional Description:
This leuprorelin acetate product is indicated for prostate cancer, endometriosis, pre-menopausal breast cancer, uterine fibroids, and central precocious puberty. Luphere is offered in two formulations, Daewoong's patented spray-dried version and an emulsion form, positioning it as one of the few bioequivalent generics available in this class.
Ratings
(0)
(0)
(0)
(0)
(0)
Comments
Filters:
Sort by:
No comments available.
Matched Products & Services
B2B matches based on trade type, category, specifications & price range
Similar Products & Services
Products & Services related to what you're viewing
People Also Viewed
Other products & services viewed by people who looked at this product
Leave your rating & comment